<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-pharmaceuticals-13-00096">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Leneva</surname>
    <given-names>I.A.</given-names>
   </name>
   <name>
    <surname>Roberts</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Govorkova</surname>
    <given-names>E.A.</given-names>
   </name>
   <name>
    <surname>Goloubeva</surname>
    <given-names>O.G.</given-names>
   </name>
   <name>
    <surname>Webster</surname>
    <given-names>R.G.</given-names>
   </name>
  </person-group>
  <article-title>The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses</article-title>
  <source>Antiviral Res.</source>
  <year>2000</year>
  <volume>48</volume>
  <fpage>101</fpage>
  <lpage>115</lpage>
  <pub-id pub-id-type="doi">10.1016/S0166-3542(00)00123-6</pub-id>
  <pub-id pub-id-type="pmid">11114412</pub-id>
 </element-citation>
</ref>
